Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment. Addict Sci Clin Pract 2024 Mar 26;19(1):22
Date
03/26/2024Pubmed ID
38528590Pubmed Central ID
PMC10964564DOI
10.1186/s13722-024-00451-zScopus ID
2-s2.0-85188585527 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
BACKGROUND: Hospitalization is a "reachable moment" for people who inject drugs (PWID), but preventive care including HIV testing, prevention and treatment is rarely offered within inpatient settings.
METHODS: We conducted a multisite, retrospective cohort study of patients with opioid use disorder with infectious complications of injection drug use hospitalized between 1/1/2018-12/31/2018. We evaluated HIV care continuum outcomes using descriptive statistics and hypothesis tests for intergroup differences.
RESULTS: 322 patients were included. Of 300 patients without known HIV, only 2 had a documented discussion of PrEP, while only 1 was prescribed PrEP on discharge. Among the 22 people with HIV (PWH), only 13 (59%) had a viral load collected during admission of whom all were viremic and 10 (45%) were successfully linked to care post-discharge. Rates of readmission, Medicaid or uninsured status, and unstable housing were high in both groups.
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.
Author List
Bradford W, Akselrod H, Bassler J, Gagnon KW, Burkholder G, Carpenter JE, Steck A, Catalanotti J, Kuo I, McGonigle K, Mai W, Notis M, Brokus C, Kattakuzhy S, Rosenthal E, Eaton EFAuthor
Kelly W. Gagnon PhD Assistant Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AftercareAnti-HIV Agents
HIV Infections
Hospitalization
Humans
Patient Discharge
Pre-Exposure Prophylaxis
Retrospective Studies
Substance Abuse, Intravenous
